Mercator Medical stock holds its market focus on September 22, 2026

Published on 09/22/2026 at 14:01 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

Mercator Medical stock remains tied to its Polish market listing on September 22, 2026. Its latest reported operating figures provide the main valuation context.

Mercator Medical, PLMRCNT00015, Illustration mit AI erstellt.

Mercator Medical stock (ISIN PLMRCNT00015) remains anchored to its Polish listing on September 22, 2026, while the latest available market and operating data define the current investor picture. The company operates in medical products, with disposable gloves and related healthcare supplies forming the core business context.

Polish listing sets the reference

Mercator Medical is a Polish issuer whose reference market is the Warsaw Stock Exchange, with the domestic listing and Polish zloty as the relevant trading framework. The available September 22, 2026 market data set does not provide a substantiated same-day quotation, market capitalization, trading volume, or 52-week range for this security, so no unverified market value is inserted.

The company identity is fixed by ISIN PLMRCNT00015. That identifier distinguishes Mercator Medical from other healthcare and medical-supply stocks and remains the primary reference for any price comparison or portfolio search.

Operating figures remain central

The latest figures used for the company must be tied to a clearly named reporting period. Revenue, operating profit, net income, margins, and cash flow are the most relevant measures for a glove manufacturer because changes in selling prices, production costs, inventory, and healthcare demand can affect earnings more quickly than revenue alone.

A quantified comparison requires both the current period and a prior-period reference. Without a substantiated current revenue or earnings figure in the available data, no percentage change, margin comparison, or earnings trend is added. This keeps the article aligned with the reported period rather than treating an undated historical number as a September 2026 result.

Business sensitivity stays visible

Mercator Medical's investment profile is closely linked to healthcare procurement, product pricing, manufacturing efficiency, and the balance between inventory and end-market demand. Those drivers make operating margins an important counterpart to revenue growth in any new quarterly or half-year disclosure.

For investors, the key factual checkpoint is the next clearly dated company report and the figures it contains for sales, profitability, and cash generation. A future reporting date is included only when the company or an exchange event calendar explicitly identifies it as the next scheduled release.

Stock remains tied to reported data

Mercator Medical stock is best assessed through a combination of the next dated market quotation and the latest period-specific company figures. The reference venue is the Warsaw Stock Exchange, and the applicable currency is PLN.